SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-056205
Filing Date
2020-02-28
Accepted
2020-02-28 16:01:37
Documents
10
Period of Report
2020-02-28

Document Format Files

Seq Description Document Type Size
1 6-K d822900d6k.htm 6-K 9534
2 EX-99.1 d822900dex991.htm EX-99.1 29888
3 GRAPHIC g822900page004.jpg GRAPHIC 169721
4 GRAPHIC g822900page005.jpg GRAPHIC 211796
5 GRAPHIC g822900page006.jpg GRAPHIC 197007
6 GRAPHIC g822900page007.jpg GRAPHIC 325317
7 GRAPHIC g822900page008.jpg GRAPHIC 149047
8 GRAPHIC g822900page009.jpg GRAPHIC 223498
9 GRAPHIC g822900page010.jpg GRAPHIC 193857
10 GRAPHIC g822900page011.jpg GRAPHIC 286215
  Complete submission text file 0001193125-20-056205.txt   2460445
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 20669941
SIC: 2834 Pharmaceutical Preparations